CRYSTAL OF REDUCED-FORM GLUTATHIONE AND METHOD FOR PRODUCING SAME

The purpose of the invention is to provide: a crystal of reduced-form glutathione in which the content of impurities, particularly L-cysteinyl-L-glycine, is reduced; and a method for producing the same. The invention relates to a crystal of reduced-form glutathione wherein, in high-performance liqui...

Full description

Saved in:
Bibliographic Details
Main Authors IGUCHI MAYA, NAGANO HIROSHI, FUKUMOTO KAZUNARI
Format Patent
LanguageChinese
English
Published 09.11.2018
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The purpose of the invention is to provide: a crystal of reduced-form glutathione in which the content of impurities, particularly L-cysteinyl-L-glycine, is reduced; and a method for producing the same. The invention relates to a crystal of reduced-form glutathione wherein, in high-performance liquid chromatography (HPLC) analysis, the peak area of L-cysteinyl-L-glycine is 0.02 or less with respect to a peak area of 100 of the reduced-form glutathione. 本发明的目的在于提供减少了杂质、特别是L-半胱氨酰基-L-甘氨酸的含量的还原型谷胱甘肽的晶体及其制造方法。本发明涉及种还原型谷胱甘肽的晶体，其中，在高效液相色谱(HPLC)分析中，相对于还原型谷胱甘肽的峰面积100，L-半胱氨酰基-L-甘氨酸的峰面积为0.02以下。
Bibliography:Application Number: CN201780016275